TGA Approval

AMIKACIN KABI amikacin (as sulfate) 250 mg/50 mL solution for injection bottle (408399)

ARTG ID

408399

ARTG Name

AMIKACIN KABI amikacin (as sulfate) 250 mg/50 mL solution for injection bottle

Sponsor

Fresenius Kabi Australia Pty Ltd

ARTG Date

April 9, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Fresenius Kabi Australia Pty Ltd.

Ingredient Name

amikacin sulfate

Empowering clinical research with data-driven insights and AI-powered tools.

AMIKACIN KABI amikacin (as sulfate) 250 mg/50 mL solution for injection bottle (408399) - TGA 批准文号 | MedPath